Dibyendu Dutta

826 total citations
42 papers, 516 citations indexed

About

Dibyendu Dutta is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Dibyendu Dutta has authored 42 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 15 papers in Hematology and 13 papers in Molecular Biology. Recurrent topics in Dibyendu Dutta's work include Hemoglobinopathies and Related Disorders (16 papers), Iron Metabolism and Disorders (13 papers) and Gut microbiota and health (6 papers). Dibyendu Dutta is often cited by papers focused on Hemoglobinopathies and Related Disorders (16 papers), Iron Metabolism and Disorders (13 papers) and Gut microbiota and health (6 papers). Dibyendu Dutta collaborates with scholars based in United States, Lebanon and Italy. Dibyendu Dutta's co-authors include Seah H. Lim, Ngee Sing Chong, Beng Guat Ooi, Nathaniel Mills, George Mo, Salomon Amar, Moro O. Salifu, Joseph Kassab, Barbara A. Methé and Alison Morris and has published in prestigious journals such as The FASEB Journal, Life Sciences and Biology of Reproduction.

In The Last Decade

Dibyendu Dutta

40 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dibyendu Dutta United States	14	166	163	149	90	72	42	516
Avital Weiss Israel	8	169 1.0×	176 1.1×	329 2.2×	83 0.9×	23 0.3×	8	645
Robert T. Perri United States	11	149 0.9×	100 0.6×	168 1.1×	53 0.6×	142 2.0×	22	647
Marian van Kraaij Netherlands	10	73 0.4×	136 0.8×	205 1.4×	153 1.7×	19 0.3×	20	592
Josée Champagne Canada	9	117 0.7×	135 0.8×	28 0.2×	50 0.6×	33 0.5×	22	593
Ashutosh Lal United States	20	210 1.3×	679 4.2×	586 3.9×	216 2.4×	46 0.6×	78	1.2k
Jia Rao China	16	232 1.4×	27 0.2×	127 0.9×	36 0.4×	25 0.3×	61	720
Vikas Bhushan United States	8	138 0.8×	41 0.3×	142 1.0×	16 0.2×	30 0.4×	30	568
Burak Bahar United States	13	189 1.1×	36 0.2×	193 1.3×	54 0.6×	66 0.9×	58	539
J Brock United Kingdom	8	113 0.7×	73 0.4×	153 1.0×	34 0.4×	20 0.3×	9	404

Countries citing papers authored by Dibyendu Dutta

Since Specialization

Citations

This map shows the geographic impact of Dibyendu Dutta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dibyendu Dutta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dibyendu Dutta more than expected).

Fields of papers citing papers by Dibyendu Dutta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dibyendu Dutta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dibyendu Dutta. The network helps show where Dibyendu Dutta may publish in the future.

Co-authorship network of co-authors of Dibyendu Dutta

This figure shows the co-authorship network connecting the top 25 collaborators of Dibyendu Dutta. A scholar is included among the top collaborators of Dibyendu Dutta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dibyendu Dutta. Dibyendu Dutta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dutta, Dibyendu, et al.. (2025). Evidence of maternal inheritance of Nizon-Isidor syndrome in an individual with GAMT and TNFRSF13B sequence variants. Journal of Human Genetics. 71(2). 105–108.

Kumar, Prashanth Ashok, et al.. (2024). Antibody-drug conjugates: Principles and opportunities. Life Sciences. 347. 122676–122676. 18 indexed citations

Lim, Seah H., et al.. (2024). GBT1118, a Voxelotor Analog, Ameliorates Hepatopathy in Sickle Cell Disease. Medicina. 60(10). 1581–1581. 1 indexed citations

Kassab, Joseph, et al.. (2023). Chronic graft-versus-host disease in pediatric patients: Differences and challenges. Blood Reviews. 60. 101054–101054. 15 indexed citations

Dutta, Dibyendu, et al.. (2023). Effects of GBT1118, a voxelotor analog, on intestinal pathophysiology in sickle cell disease. British Journal of Haematology. 202(1). 184–194. 4 indexed citations

Kumar, Prashanth Ashok, et al.. (2023). Utilization and outcome disparities in allogeneic hematopoietic stem cell transplant in the United States. European Journal Of Haematology. 112(3). 328–338. 6 indexed citations

Kumar, Prashanth Ashok, et al.. (2023). Intestinal barrier functions in hematologic and oncologic diseases. Journal of Translational Medicine. 21(1). 233–233. 15 indexed citations

Sahu, Sounak, et al.. (2023). CRISPR-based precision medicine for hematologic disorders: Advancements, challenges, and prospects. Life Sciences. 333. 122165–122165. 2 indexed citations

Dutta, Dibyendu, et al.. (2022). L-glutamine for sickle cell disease: more than reducing redox. Annals of Hematology. 101(8). 1645–1654. 13 indexed citations

10.

Kumar, Prashanth Ashok, et al.. (2022). Radioimmunoconjugates in the age of modern immuno-oncology. Life Sciences. 310. 121126–121126. 12 indexed citations

11.

Dutta, Dibyendu, et al.. (2022). Genes modulating intestinal permeability and microbial community are dysregulated in sickle cell disease. Annals of Hematology. 101(5). 1009–1013. 6 indexed citations

12.

Dutta, Dibyendu, et al.. (2021). Sperm protein 17 targeting for epithelial ovarian cancer treatment in the era of modern immunoengineering. Molecular Therapy — Oncolytics. 23. 378–386. 1 indexed citations

13.

Mo, George, et al.. (2021). Antibiotic use in adults during sickle cell vaso‐occlusive crisis: Is it time for a controlled trial?. British Journal of Haematology. 193(6). 1281–1283. 2 indexed citations

14.

Mo, George, et al.. (2021). Obesity and diabetes mellitus in patients with sickle cell disease. Annals of Hematology. 100(9). 2203–2205. 8 indexed citations

15.

Mo, George, et al.. (2021). Chronic opioid use in patients with sickle cell disease. Hematology. 26(1). 415–416. 3 indexed citations

16.

Dutta, Dibyendu & Seah H. Lim. (2020). Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions. Biomarker Research. 8(1). 31–31. 41 indexed citations

17.

Dutta, Dibyendu, et al.. (2019). Analysis of chemical constituents in mainstream bidi smoke. BMC Chemistry. 13(1). 93–93. 11 indexed citations

18.

Dutta, Dibyendu, et al.. (2019). Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention. British Journal of Haematology. 188(4). 488–493. 18 indexed citations

19.

Dutta, Dibyendu, Ngee Sing Chong, & Seah H. Lim. (2018). Endogenous volatile organic compounds in acute myeloid leukemia: origins and potential clinical applications. Journal of Breath Research. 12(3). 34002–34002. 15 indexed citations

20.

Dutta, Dibyendu, et al.. (2017). Testosterone regulates granzyme K expression in rat testes. Endocrine Regulations. 51(4). 193–204. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact